Translational Pathology & Spatial Biology CRO

From Tissue to Insight

High-resolution spatial pathology fluorescence tissue image

Pathora Bio is building an execution-focused translational pathology CRO for histology, multiplex IHC/IF, digital pathology, biomarker analytics, spatial-ready tissue workflows, and clinical trial support.

Histology

Multiplex IHC/IF

Digital Pathology

Biomarker Analytics

Clinical Trial Support

ISH Assays

Spatial-Ready QC

Explore Services Investor Opportunities

The Business Case

A pathology infrastructure business built around execution

Pathora Bio translates advanced tissue science into a clear business problem: fragmented academic and vendor workflows delay tissue biomarker programs for pharma, biotech, and clinical research teams.

Operational Pain

Clients lose time when tissue retrieval, pathology review, sectioning, staining, imaging, and analysis are split across disconnected groups.

Premium Service Model

Positioned as a high-end translational pathology CRO, not a commodity histology lab.

Miami-Based, Global Reach

Headquartered in Miami with a scalable model for national and international pharma, biotech, and translational research clients.

Investor-Friendly Story

The value is simple: faster execution, better tissue biomarker data, accountable delivery, and CRO-grade quality systems.

Core Services

Integrated tissue biomarker services

Flexible specimen intake and end-to-end project ownership for pharma, biotech, and translational oncology teams.

Histology & H&E

FFPE sectioning, H&E, unstained slides, TMAs, and research-ready tissue preparation.

IHC / IF Assay Development

Targeted biomarker staining, assay optimization, controls, and reproducibility-focused workflows.

ISH Assays

RNA/DNA in situ hybridization assay support, including FISH/RNAscope-style workflows and tissue-based molecular localization.

Multiplex Imaging

Multiplex IF/IHC and spatial-ready tissue imaging for translational biomarker programs.

Digital Pathology Analytics

Quantitative pathology, segmentation, biomarker scoring, spatial analysis, and report-ready outputs.

Workflow

End-to-end tissue-to-data execution

One accountable workflow across intake, pathology review, histology, staining, imaging, analysis, and delivery.

Specimen Intake

Blocks, slides, TMAs, sections, stained slides, WSIs, and de-identified data.

Pathology Review

ROI selection, tissue suitability, necrosis, tumor content, and assay feasibility.

Histology & Assay QC

Sectioning, H&E, staining controls, panel verification, and tissue-readiness gates.

Imaging & Analysis

Whole-slide imaging, multiplex imaging, digital pathology, and biomarker analytics.

Report Delivery

Structured deliverables, image files, quantified data, QC notes, and scientific interpretation.

Innovation

Interactive scientific workflow

Explore the Pathora Bio interactive workflow platform. On phones, a mobile workflow card appears first; desktop and tablet users see the full widescreen interactive slide workflow.

Integrated Translational Pathology Platform

Visualizes scientific consultation, assay strategy, sample processing, analysis, and secure delivery.

Launch Interactive Workflow

Standards & Compliance

Quality systems built into the operating model

Pathora Bio is designed around reproducibility, traceability, QA/QC, regulatory readiness, specimen tracking, SOPs, and CRO-grade documentation.

CLIA

CLIA Readiness Framework

Clinical laboratory operational standards, QC oversight, specimen traceability, and scalable compliance workflows.

CAP

CAP-Aligned Quality Systems

SOP-driven design supporting reproducibility, audit readiness, workflow standardization, and CRO-grade execution.

Quality & Compliance Infrastructure

Accountability, specimen tracking, reporting consistency, operational transparency, and high-end translational pathology workflows.

CLIACLIA Roadmap

CAPCAP Readiness

ISOISO-Aligned Process

GLPGLP Principles

Investment Opportunity

Investor Opportunities

Pathora Bio is being built around a practical bottleneck in cancer and disease research: tissue biomarker programs are often slowed by fragmented handoffs, unclear workflow ownership, and inconsistent outputs. The company integrates pathology, imaging, AI-assisted digital analysis, and biomarker reporting into one accountable specimen-to-insight workflow for biotech, pharma, and translational research teams.

$8B+CRO histopathology & biomarker services market

22%Annual growth in multiplex IF & spatial biology adoption

$2.5MSeed funding target for operational buildout

GlobalPharma, biotech & translational research reach

Florida Hub USA Nationwide Europe Asia-Pacific Worldwide

Founder & Scientific Leadership

Thomas Lisse, PhD

Founder & Chief Scientific Officer

Founder-level scientific leadership with deep experience across translational pathology, spatial biology, histology, multiplex tissue imaging, digital pathology, biomarker analytics, functional genomics, and cancer research workflows.

Experience spans academic cancer center operations, core facility execution, industry R&D/scientific affairs leadership, CRO-style service delivery, tissue QC, assay development, imaging platforms, and client-facing biomarker deliverables.

Translational Pathology Spatial Biology Multiplex Imaging Digital Pathology Functional Genomics CRO-Grade Execution

Digital Pathology & AI Leadership

Enrico Capobianco, PhD

Chief Digital Pathology & AI Officer

Quantitative pathology and AI leadership with a PhD in Statistics and international research experience across Stanford, Berkeley, Northwestern, Boston University, University of Miami, Jackson Laboratory, LSE, NBI, CWI, CNR, CRS4, and IHES.

Background spans statistical modeling, systems medicine, complex networks, multiomics, medical imaging, and cancer research, with emphasis on turning complex biomedical data into interpretable, reproducible signals.

Adds a technology layer to Pathora Bio’s tissue-to-data platform by supporting AI-assisted digital pathology, scalable image analysis, and biomarker feature extraction for cancer and disease research.

Statistics AI / ML / DL Systems Medicine Complex Networks Multiomics Medical Imaging Cancer Research Quantitative Pathology

Remaining Leadership & Advisory Buildout

Chief Executive Officer

Planned business leader to support fundraising, commercial strategy, partnerships, and company scale-up.

MD / PhD Pathologist

Advisor/medical director track to support pathology review, biomarker interpretation, clinical alignment, and scientific credibility.

Operations & QA Lead

Operations and QA leadership for lab workflow, SOPs, quality systems, CAP/CLIA readiness, and project execution.

Request Investor Deck

Contact

Ready to advance your translational research?

Submit your inquiry and a member of the scientific team will respond promptly.

Email: info@pathorabio.com
Phone: 786-519-3564
LinkedIn: Pathora Bio